MedPath

Codeine

Generic Name
Codeine
Brand Names
Ascomp, Cheratussin, Cheratussin Dac, Codar Ar, Codar D, Codar Gf, Codeine Contin, Covan, Damylin With Codeine, Fioricet With Codeine, Histex Ac, Linctus Codeine Blanc, M-clear Wc, M-end PE, Mar-cof BP, Mar-cof Cg, Mersyndol, Ninjacof Xg, Pseudodine C, Robaxacet-8, Robaxisal, Triacin-C, Trianal C, Triatec, Triatec-30, Triatec-8, Tusnel C, Tuxarin, Tuzistra, Tylenol With Codeine
Drug Type
Small Molecule
Chemical Formula
C18H21NO3
CAS Number
76-57-3
Unique Ingredient Identifier
UX6OWY2V7J

Overview

The relief of pain (analgesia) is a primary goal for enhancing the quality of life of patients and for increasing the ability of patients to engage in day to day activities. Codeine, an opioid analgesic, was originally approved in the US in 1950 and is a drug used to decrease pain by increasing the threshold for pain without impairing consciousness or altering other sensory functions. Opiates such as codeine are derived from the poppy plant, Papaver somniferum (Papaveraceae). Codeine is utilized as a central analgesic, sedative, hypnotic, antinociceptive, and antiperistaltic agent, and is also recommended in certain diseases with incessant coughing.

Background

The relief of pain (analgesia) is a primary goal for enhancing the quality of life of patients and for increasing the ability of patients to engage in day to day activities. Codeine, an opioid analgesic, was originally approved in the US in 1950 and is a drug used to decrease pain by increasing the threshold for pain without impairing consciousness or altering other sensory functions. Opiates such as codeine are derived from the poppy plant, Papaver somniferum (Papaveraceae). Codeine is utilized as a central analgesic, sedative, hypnotic, antinociceptive, and antiperistaltic agent, and is also recommended in certain diseases with incessant coughing.

Indication

Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate . The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above , .

Associated Conditions

  • Common Cold
  • Cough
  • Flu caused by Influenza
  • Mild pain
  • Pain
  • Severe Pain
  • Dry cough
  • Moderate Pain
  • Upper respiratory symptoms

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/04/02
Phase 4
Recruiting
2023/03/16
Phase 4
Completed
2022/11/23
Phase 3
Completed
2020/11/23
Phase 3
Completed
Brazilian Clinical Research Institute
2018/12/21
Phase 4
Completed
2018/03/27
Not Applicable
Terminated
2017/11/07
Phase 1
Completed
2017/08/04
Not Applicable
Completed
2016/04/13
Phase 1
Completed
Michael Camilleri
2015/12/09
Phase 3
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Northwind Pharmaceuticals, LLC
51655-910
ORAL
30 mg in 1 1
6/14/2023
DIRECT RX
61919-023
ORAL
30 mg in 1 1
3/29/2023
Physicians Total Care, Inc.
54868-0378
ORAL
12 mg in 5 mL
11/10/2010
Akorn
50383-338
ORAL
24 mg in 10 mL
5/25/2022
Nostrum Laboratories, Inc.
70408-185
ORAL
10 mg in 5 mL
12/11/2018
Hikma Pharmaceuticals USA Inc.
0054-0243
ORAL
15 mg in 1 1
3/15/2021
A-S Medication Solutions
50090-5204
ORAL
60 mg in 1 1
5/20/2021
Direct_Rx
72189-486
ORAL
10 mg in 5 mL
6/2/2023
Blenheim Pharmacal, Inc.
10544-100
ORAL
30 mg in 1 1
12/31/2013
REMEDYREPACK INC.
70518-2764
ORAL
60 mg in 1 1
3/6/2024

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
Linctus Tussis Rubra 10mg/5ml
SIN06870P
ELIXIR
10 mg/5 ml
3/4/1992
CODEINE TABLETS 30 mg
SIN07044P
TABLET
30 mg
6/3/1992
PROMELIX SYRUP
SIN06423P
SYRUP
9 mg/5 ml
7/8/1991
PROCODIN SYRUP
SIN04075P
SYRUP
9 mg/5 ml
3/28/1990
UNISEDYL FORTE LINCTUS
SIN02919P
ELIXIR
10 mg/5 ml
5/22/1989
BEACTAFED CO SYRUP
SIN03140P
SYRUP
10 mg/5 ml
5/30/1989
COLINCTUS 10 MIXTURE 10 mg/5 ml
SIN03413P
ELIXIR
10 mg/5 ml
6/22/1989
COPHADYL COUGH LINCTUS
SIN09071P
ELIXIR
9 mg/5 ml
12/14/1996
L.T.R. COUGH LINCTUS 10 mg/5 ml
SIN03699P
ELIXIR
10 mg/5 ml
8/5/1989
FEDAC COMPOUND LINCTUS
SIN03195P
ELIXIR
10 mg/5 ml
6/1/1989

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Codeine Phosphate Injection
国药准字H21021146
化学药品
注射剂
7/13/2020
Codeine Phosphate Injection
国药准字H21021147
化学药品
注射剂
7/13/2020
Codeine Phosphate Injection
国药准字H42022494
化学药品
注射剂
6/14/2022
Codeine Phosphate Injection
国药准字H42021991
化学药品
注射剂
6/14/2022
Codeine Phosphate Sustained-release Tablets
国药准字H10980001
化学药品
片剂(缓释)
8/24/2020
Codeine Phosphate Tablets
国药准字H11020673
化学药品
片剂
6/28/2020
Codeine Phosphate Tablets
国药准字H63020056
化学药品
片剂
5/8/2020
Codeine Phosphate Tablets
国药准字H32022568
化学药品
片剂
7/14/2020
Codeine Phosphate Tablets
国药准字H63020055
化学药品
片剂
5/8/2020
Codeine Phosphate Tablets
国药准字H11020672
化学药品
片剂
6/28/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
PROSEDYL COUGH SYRUP
N/A
N/A
N/A
8/20/1985
MOTRACK COUGH SYRUP
N/A
N/A
N/A
9/14/2010
MERSIDYL SYRUP
N/A
N/A
N/A
2/25/1986
NICE PHENDYL-B LINCTUS
N/A
neochem pharmaceutical laboratories ltd.
N/A
N/A
7/15/1982
NEODINE TAB
N/A
unicorn laboratories o/b american unicorn laboratories limited
N/A
N/A
1/11/2002
COCLEAN SYRUP
N/A
N/A
N/A
6/15/2001
PECOLIN SYRUP
N/A
medipharma ltd
N/A
N/A
3/9/1992
OROSEDYL COUGH SYRUP
N/A
N/A
N/A
2/8/2019
SUPHENIN SYRUP
N/A
medipharma ltd
N/A
N/A
3/28/2001
PACTOREX SYRUP
N/A
N/A
N/A
4/20/1979

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath